Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

Central China Normal University synthesizes new TRK inhibitors

Oct. 6, 2020

Hangzhou Innogate Pharma discovers ALK/mutant EGFR/MAP4K1 inhibitors

Oct. 6, 2020

New JAK inhibitors identified at Beijing Scitech-Mq Pharmaceuticals

Oct. 6, 2020

Lantern Pharma and Georgetown University advance development of LP-184

Oct. 6, 2020

Carcinogens need not be mutagens

Oct. 6, 2020

A potent and selective allosteric inhibitor of SHP2 that overcomes tumor resistance to osimertinib

Oct. 6, 2020

Results reported from nextMONARCH and monarchE studies of abemaciclib

Oct. 5, 2020

MEN-1611 plus trastuzumab +/- fulvestrant well tolerated in phase I breast cancer trial

Oct. 5, 2020

Preliminary first-in-human data presented for CLN-081

Oct. 5, 2020

Lead Discovery Center and SOTIO patent new compounds for cancer

Oct. 5, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 15, 2026.
AAIC 2026: Age of amyloid is being joined by time of tau
BioWorld
The Alzheimer’s Association International Conference (AAIC) is the world’s biggest dementia conference. And at the AAIC 2026 meeting, there is big buzz around...
Celia trial: data strong, analysts skeptical
BioWorld
Tuesday brought what was arguably the most anticipated presentation of the 2026 Alzheimer’s Association International Conference when Catherine Mummery, head of...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 14, 2026
GABA signaling linked to immune resistance in some tumors
BioWorld
Certain cancers that contain organized clusters of immune cells known as tertiary lymphoid structures (TLS) do not respond to treatment as well as expected. Even...